Meta's In-House Chip Plans Boost AMAT Sentiment, But Fundamentals Remain Stretched

What happened

Meta's decision to develop its own chips boosts Applied Materials and other equipment makers by driving additional wafer fab equipment demand. However, the DeepValue master report maintains a WAIT rating on AMAT, citing a P/E of 67.6 and EV/EBITDA of 59.5 that already price in a sustained AI-driven upcycle. The report highlights key risks: export-control compliance overhangs from a BIS settlement, management's expectation that WFE market share will be 'below target' for CY2025, and heavy insider selling in mid-June. While Meta's move supports the long-term AI demand narrative, it does not alleviate near-term valuation concerns or the asymmetric downside from potential export restrictions. Investors should watch for Q3 FY2026 results and compliance updates before considering entry near the $600 attractive entry price.

Implication

The Meta chip news reinforces the AI-driven secular demand for AMAT's equipment but does not change the near-term risk/reward calculus. At $723, the stock trades at 67.6x trailing earnings, leaving little room for error if export restrictions or market share issues materialize. The DeepValue report's bear case ($600) reflects a scenario where China access tightens further, which is a real risk given the BIS settlement. Until AMAT demonstrates that its advanced packaging revenue growth (>50% in CY26) translates into durable outgrowth and that compliance obligations are met, the stock should be avoided. The thesis delta is minimal: the Meta news adds a tailwind but does not outweigh the valuation and regulatory headwinds.

Thesis delta

The Meta chip announcement provides a marginal positive demand signal for AMAT, but it does not alter the core thesis that the stock is fully valued and exposed to discontinuous export risk. The investment case still hinges on delivery of packaging growth and compliance milestones, with the WAIT rating unchanged and a better entry point near $600.